US Patent Issued to California Institute of Technology on Aug. 4 for "Antibodies which have specificity to a sarbecovirus spike protein receptor-binding domain and methods of use thereof for treating a coronavirus infection" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,321, issued on Aug. 4, was assigned to California Institute of Technology (Pasadena, Calif.).

"Antibodies which have specificity to a sarbecovirus spike protein receptor-binding domain and methods of use thereof for treating a coronavirus infection" was invented by Pamela J. Bjorkman (Pasadena, Calif.), Alexander A. Cohen (Pasadena, Calif.), Chengcheng Fan (Pasadena, Calif.), John C. Williams (Duarte, Calif.) and Miso Park (Duarte, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein receptor binding domain. Also provided are compositions, met...